王金平

[摘要] 目的 分析全视网膜的光凝术针对于糖尿病所致视网膜的病变患者泪液分泌相关影响。方法 该文将该院2018年3月—2019年4月收治糖尿病所致视网膜病变的100例患者纳入研究对象范围，以就诊顺序将患者平分两组，每组50例。常规组实施药物治疗，研究组实施全视网膜的光凝术，观察两组效果。结果 相比常规组，经治疗后研究组泪液分泌状况与BUT指标得以有效改善，疗效较高，差异有统计学意义（P<0.05）。结论 针对于糖尿病所致视网膜的病变患者，全视网膜的光凝术可显著改善患者泪液分泌状况与BUT指标，获取较高的临床疗效，有着极高的临床应用价值及意义。

[关键词] 视网膜病变;糖尿病;泪液分泌;全视网膜光凝术

[中图分类号] R77          [文献标识码] A          [文章编号] 1672-4062（2020）06（a）-0183-03

[Abstract] Objective To analyze the effect of panretinal photocoagulation on tear secretion in patients with retinal lesions caused by diabetes. Methods In this article， 100 patients with retinal lesions due to diabetes admitted to the hospital from March 2018 to April 2019 were included in the scope of the study. The patients were divided into two groups in the order of treatment， 50 cases in each group. The conventional group was given drug treatment， and the research group was given photocoagulation of the whole retina to observe the effects of the two groups. Results Compared with the conventional group， the tear secretion status and BUT index of the research group were effectively improved after treatment， and the efficacy was higher， the difference was statistically significant（P<0.05）. Conclusion For patients with retinal lesions caused by diabetes， panretinal photocoagulation can significantly improve patients' tear secretion and BUT index， and obtain high clinical efficacy， which has extremely high clinical application value and significance.

[Key words] Retinopathy; Diabetes; Tear secretion; Panretinal photocoagulation

糖尿病所致视网膜的病变（DR），属于糖尿病患者致盲重要因素。视网膜的光凝术，属于DR临床治疗当中最具有效性的一种手段，可挽救大部分糖尿病患者视力。然则，全视网膜的光凝术开展临床治疗期间，也有着破坏性存在，它所导致的眼表功能性损害，备受国内外广大医学研究者们普遍关注[1]。部分医学专家及研究学者们表明了全视网膜的光凝术治疗后，患者角膜知觉会有较为明显的变化，相关临床医学报道明确指出了全视网膜的光凝术治疗后，患者角膜上皮组织神经密度、角膜实际敏感度与角膜的上皮层厚度均有所降低[2]。那么，为深入分析全视网膜的光凝术针对于糖尿病所致视网膜的病变患者泪液分泌相关影响，该文将该院2018年3月—2019年4月收治糖尿病所致视网膜的病变100例患者纳入研究对象范围，分别实施药物治疗、全视网膜的光凝术，现报道如下。……